- Cell and molecular biology
- Epidemiology, prevention and public health
- Experimental therapeutics and drug development
- Genetics, genomics and epigenetics
- Infection, immunity and cancer vaccines
- Medical and radiation oncology
- Surgical oncology, cancer imaging and interventional therapeutics
- Systems biology, post-genomic analysis and emerging technologies
The Editors of BMC Cancer and BMC Microbiology are exited to announce the launch and invite of submissions to our ‘Microbiome and Cancer’ cross journal collection. Guest edited by Prof. Christopher Staley and Dr. Sean Devlin.
Open for submissions until 1st May 2021. Submit now!
Support and Guidance
BMC Series Focus Issue
Research data are the foundations of reliable and reproducible science. This month, we would like to highlight different ways authors were able to publish and share their data by choosing the BMC series.
Featured video: Microparticles, breast cancer's secret weapon?
How do physicians and nurses perceive the benefits of clinical trial participation compared with standard care? Is it justified to claim that clinical trial participation improves outcomes for cancer patients? Zandra Nielsen et al. present their latest findings of a mixed-methods study in Scandinavia.
Aims and scope
Click here to view which Articles have been shared most in the last 6 months!
BMC Series Blog
Follow Nobel Prize laureates James P. Allison's and Tasuku Honjo's footsteps and experience the genesis of a new field of cancer therapy. BMC Cancer Editorial Board Member Dr. Sheng Guo from Pittsburgh University takes us on an exciting journey of discovery...
2019 Journal Metrics
3.15 - 2-year Impact Factor
3.432 - 5-year Impact Factor
1.021 - Source Normalized Impact per Paper (SNIP)
1.186 - SCImago Journal Rank (SJR)
Social Media Impact